Insider Transactions Reported by 25 Insiders of Fulcrum Therapeutics, Inc.

Symbol
FULC on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Fulcrum Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
RA CAPITAL MANAGEMENT, L.P. 10%+ Owner $90,688,320 -$58,377,021 -39% 08 Dec 2025
Third Rock Ventures III, L.P. 10%+ Owner $14,250,729 13 Dec 2022
Mark J. Levin Director, 10%+ Owner $13,365,787 10 Nov 2021
Robert J. Gould Director $4,877,870 -$489,441 -9.1% 02 Feb 2026
Curtis Gale Oltmans Chief Legal Officer $132,455 -$44,600 -25% 02 Feb 2026
Christopher Moxham Chief Scientific Officer $102,845 10 Aug 2021
Greg Tourangeau Principal Accounting Officer $71,153 -$2,520 -3.4% 02 Feb 2026
Kate Haviland Director 26 Jun 2025
Bryan Stuart President & Chief Executive Officer, Director 19 Jan 2022
James J. Collins Director 17 Jun 2024
Alan Ezekowitz Director 26 Jun 2025
Peter G. Thomson VP Finance & Accounting 19 Jan 2022
Sonja Banks Director 26 Jun 2025
Melvin H. Hayes III Chief Operating Officer 26 Apr 2023
Judith Dunn President, Research & Development 19 Jan 2022
Alan A. Musso Chief Financial Officer 02 Feb 2026
Esther Rajavelu Chief Financial Officer 09 Feb 2023
Alex Sapir President & Chief Executive Officer, Director 02 Feb 2026
Santiago Arroyo Chief Medical Officer 07 Nov 2022
Katina Dorton Director 26 Jun 2025
Rachel K. King Director 26 Jun 2025
Patrick Taylor Horn Chief Medical Officer 18 Mar 2024
Colin Hill Director 26 Jun 2025
James A. Geraghty Director 26 Jun 2025
Christopher Morabito Chief Medical Officer 19 Jan 2022

Recent Insider Transactions by Companies or Individuals for Fulcrum Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Curtis Gale Oltmans FULC Stock Option (right to buy) Award 170,000 170,000 02 Feb 2026 Direct
Greg Tourangeau FULC Stock Option (right to buy) Award 57,000 57,000 02 Feb 2026 Direct
Alex Sapir FULC Stock option - Right to Buy Award 650,000 650,000 02 Feb 2026 Direct
Robert J. Gould FULC Common Stock Sale -3.19% $160,857 $10.72 -15,000 454,864 02 Feb 2026 Direct
Alan A. Musso FULC Stock Option (right to buy) Award 170,000 170,000 02 Feb 2026 Direct
Robert J. Gould FULC Common Stock Sale -3.09% $163,089 $10.87 -15,000 469,864 02 Jan 2026 Direct
Curtis Gale Oltmans FULC Common Stock Sale -25.2% $44,600 $12.92 -3,452 10,252 15 Dec 2025 Direct
Ra Capital Management, L.P. FULC Common Stock Sale -40.8% $58,377,021 $13.98 -4,175,139 6,053,960 08 Dec 2025 See footnotes
Robert J. Gould FULC Common Stock Sale -3% $165,495 $11.03 -15,000 484,864 19 Nov 2025 Direct
James A. Geraghty FULC Stock Option (right to buy) Award 36,000 36,000 26 Jun 2025 Direct
Katina Dorton FULC Stock Option (right to buy) Award 36,000 36,000 26 Jun 2025 Direct
Kate Haviland FULC Stock Option (right to buy) Award 36,000 36,000 26 Jun 2025 Direct
Rachel K. King FULC Stock Option (right to buy) Award 36,000 36,000 26 Jun 2025 Direct
Colin Hill FULC Stock Option (right to buy) Award 36,000 36,000 26 Jun 2025 Direct
Sonja Banks FULC Stock Option (right to buy) Award 36,000 36,000 26 Jun 2025 Direct
Robert J. Gould FULC Stock Option (right to buy) Award 36,000 36,000 26 Jun 2025 Direct
Alan Ezekowitz FULC Stock Option (right to buy) Award 36,000 36,000 26 Jun 2025 Direct
Greg Tourangeau FULC Common Stock Sale -3.42% $2,520 $5.06 -498 14,062 08 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.